PURAPHARM (01498) announced that, effective April 27, 2026, Mr. Li Jiahui has been appointed as an Independent Non-Executive Director, as well as a member of the Board Audit Committee, the Board Remuneration Committee, and the Board Nomination Committee. Professor Wu Hongwei has been appointed as an Independent Non-Executive Director and a member of the Audit Committee, the Remuneration Committee, and the Nomination Committee.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.